Recombinant human interleukin 4 (IL-4) given as daily subcutaneous injections – a phase I dose toxicity trial (Q35994341)
scientific article published on July 1, 1992
Language:
(P31) (Q13442814)
(P50) (Q56850325)
(Q66985993)
(P304) 204-210
(P407) (Q1860)
(P433) 1
(P478) 66
(P577) Wednesday, July 1, 1992
(P921) (Q5452194)
(Q162555)
(P953) https://europepmc.org/articles/PMC1977892
https://europepmc.org/articles/PMC1977892?pdf=render
https://www.nature.com/articles/bjc1992243.pdf
https://www.nature.com/articles/bjc1992243
(P1433) (Q326309)
(P1476) "Recombinant human interleukin 4 (IL-4) given as daily subcutaneous injections--a phase I dose toxicity trial" (language: en)
"Recombinant human interleukin 4 (IL-4) given as daily subcutaneous injections – a phase I dose toxicity trial" (language: en)
(P2093) J. H. Scarffe
A. Ghosh
C. M. Heyworth
E. Bonnem
N. Testa
T. M. Dexter
(P2860) (Q29620070)
(Q36346214)
(Q37571189)
(Q36354355)
(Q36352362)
(Q37853174)
(Q37699523)
(Q42800389)
(Q42222335)
(Q41853814)
(Q46076238)
(Q42816834)
(Q54357456)
(Q41837534)
(Q41841133)
(Q41839327)
(Q45847466)
(Q42167243)
(Q41742638)
(Q70044299)
(Q69059603)
(Q68099238)
(Q68091384)
(Q68825063)
(Q68738136)
(Q68447393)
(Q70221938)
other details
description scientific article published on July 1, 1992

External Links